Methods of preparing tecovirimat
Disclosed are methods for the preparation of Tecovirimat for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases caused by the orthopoxvirus.
1. A method for producing N-[(3aR,4R,4aR,5aS,6S,6aS)-3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl]-4-(trifluoromethyl)-benzamide, said method comprising:
(a) reacting compound 7 having formula:
with 4-Iodobenzoyl chloride (compound 12) to form compound 13 having formula:
(b) reacting compound 13 with methyl 2,2-difluoro-2-(fluorosulfonyl)acetate; and
(c) collecting N-[(3aR,4R,4aR,5aS,6S,6aS)-3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl]-4-(trifluoromethyl)-benzamide.
2. The method of claim 1 , wherein a base is present in the reaction of step (a), wherein said base is selected from the group consisting of: pyridine, 4-dimethylaminopyridine, triethylamine and diisopropylethylamine.
3. The method of claim 1 , wherein step (a) is carried out under nitrogen atmosphere at a temperature below 20° C.
4. The method of claim 1 , wherein step (b) is carried out in the presence of dimethylformamide, methyl 2,2-difluoro-2-(fluorosulfonyl)acetate and copper (I) iodide.
5. The method of claim 1 , wherein said N-[(3aR,4R,4aR,5aS,6S,6aS)-3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl]-4-(trifluoromethyl)-benzamide collected in step (c) is further purified by column chromatography.